ciprofloxacin has been researched along with cefuroxime in 130 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (6.15) | 18.7374 |
| 1990's | 40 (30.77) | 18.2507 |
| 2000's | 40 (30.77) | 29.6817 |
| 2010's | 31 (23.85) | 24.3611 |
| 2020's | 11 (8.46) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JM; Cooper, MA; Wise, R | 1 |
| Johnson, DM; Jones, RN | 1 |
| Andersen, BM; Bergan, T; Brubakk, O; Bruun, JN; Døskeland, B; Hellum, KB; Hopen, G; Kalager, T; Rahm, V; von der Lippe, E | 1 |
| Gentry, LO | 1 |
| Cherubin, CE; Eng, RH; Smith, SM; Tan, EN | 1 |
| Gemmell, CG; McArdle, CS; Morran, CG; Pettit, L; Sleigh, JD; Tillotson, GS | 1 |
| Geary, I; Spencer, RC; Wilcox, MH | 1 |
| Kronvall, G; Ringertz, S; Rylander, M | 1 |
| Denyer, SP; Finch, RG; Smith, DG; Wilcox, MH; Williams, P | 1 |
| Duriex, DE; Westblom, TU | 1 |
| Brouwer, WK; Hoogkamp-Korstanje, JA; Kuiper, KM | 1 |
| Conneally, E; Kavanagh, P; Keogh, JA; Mellotte, G; Moráin, CO; Mulvihill, E; O'Riordan, T | 1 |
| Edwards, R; Filik, R; Finch, RG; Wilcox, MH | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Andrews, JM; Ashby, JP; Matthews, RS; Wise, R | 1 |
| Andrews, JM; Ashby, JP; Wise, R | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Williams, P | 1 |
| Finch, R; Martin, J; Pilkington, R | 1 |
| Dalman, P; Drott, C; Holm, J; Ivarsson, L; Jivegård, L; Karlström, L; Odén, A; Pedersen, P; Rahm, V; Risberg, B | 1 |
| Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
| Bíró, L; Hodics, T; Koltai, M; Lengyel, M | 1 |
| Chakravarthy, S; George, J; Jacob, CK; John, GT | 1 |
| Dhoore, F; Verbist, L | 1 |
| Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
| Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
| Hall, FC; Hasan, S; Maidment, G | 1 |
| Anderson, JR; Gemmell, CG; McArdle, CS; Morran, CG; Pettit, L; Sleigh, JD; Tillotson, GS | 1 |
| Chapman, RW; Culshaw, KD; Mehal, WZ; Tillotson, GS | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
| Andrews, JM; Brenwald, N; Wise, R | 1 |
| Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
| Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
| Bierkens, AF; de la Rosette, JJ; Debruyne, FM; Doesburg, W; Ezz el Din, KE; Hendrikx, AJ; Horrevorts, A | 1 |
| Feeney, R; Jones, EM; Kirkpatrick, BL; MacGowan, AP; Reeves, DS | 1 |
| Collins, JJ; Giguere, GC; Hook, EW; McCormack, WM; Mussari, KL; Rompalo, A; Schwebke, JR; Thorpe, EM | 1 |
| Jepras, RI; Paul, FE; Pearson, SC; Wilkinson, MJ | 1 |
| Echols, RM; Heyd, A; Klein, GL; Whalen, E | 1 |
| Joseph, EM; Sperling, NM | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
| Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R | 1 |
| Samaranayake, LP; Sedgley, CM | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Anzueto, A; Grossman, RF; Rizzo, JA | 1 |
| Agrawal, CS; Gupta, AK; Sehgal, R; Singh, RK | 1 |
| Casado, E; Giménez, M; Olivé, A; Ortiz-Santamaria, V | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Astrup, AV; Høiby, N; Larsen, LA; Raben, A; Tvede, M | 1 |
| Navarro, V; Roig, P; Salavert, M | 1 |
| BarrosD'sa, S; Evans, PD; Gupta, SK; White, DG | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Gransden, W; Ladhani, S | 1 |
| Hong, M; Tong, MH; Yao, DM | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Bogner, JR; Draenert, R; Hellers, J; Kunzelmann, M; Roggenkamp, A | 1 |
| Allan, RC; Melzer, M; Moghal, M; Wijesuriya, V | 1 |
| Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM | 1 |
| Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E | 1 |
| Onche, II; Thanni, LO; Yinusa, W | 1 |
| Edwards, CM; Fitzpatrick, RW | 1 |
| Karabelis, A; Kordossis, T; Kosmas, C; Sipsas, NV; Skopelitis, E; Tsavaris, N; Vadiaka, M; Ziakas, PD | 1 |
| Pezzilli, R | 1 |
| Bowler, IC; Hornby, SJ; Orlans, HO | 1 |
| Baker, M; Gurbaxani, A; Nash, J; Shalchi, Z | 1 |
| Fadeyi, A; Olajide, TG; Segun-Busari, S | 1 |
| Ahmad, S; Cullen, IM; Fennell, JP; Flynn, R; Grainger, R; Manecksha, RP; McCullagh, E; McDermott, TE; Murphy, P; O'Kelly, F; Thornhill, JA | 1 |
| Bamiro, BS; Suleiman, IA; Tayo, F | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Gil-Fortuño, M; Lázaro-Santander, R; Manzanet-Andrés, G; Tirado-Balaguer, MD; Yagüe-Muñoz, A | 1 |
| Manson, W; Ott, A; van der Vusse, ML; van Son, WJ | 1 |
| Bergmann, PA; Liodaki, ME; Mailänder, P; Mauss, KL; Siemers, F; Stang, F | 1 |
| Abriouel, H; Fernández Fuentes, MA; Gadea, R; Gálvez, A; Ortega, E; Pérez Pulido, R | 1 |
| Mihçiokur, H; Oğuz, M | 1 |
| Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
| Arslan, H; Azap, OK; Can, F; Ergonul, O; Ispir, P; Seref, C | 1 |
| Andersen, MH; Arendrup, MC; Bestle, MH; Cozzi-Lepri, A; Drenck, NE; Grarup, J; Hein, L; Helweg-Larsen, J; Jensen, JU; Johansen, ME; Larsen, KM; Lauritsen, AØ; Lundgren, B; Lundgren, JD; Løken, J; Mohr, T; Møller, JK; Olesen, B; Petersen, JA; Reinholdt, K; Strange, D; Søe-Jensen, P; Thormar, K; Tousi, H; Østergaard, C | 1 |
| Attin, T; Rechenberg, DK; Schmidlin, PR; Thurnheer, T; Zaruba, M | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
| Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
| Almirante, B; Andreu, A; Bosch-Nicolau, P; Falcó, V; Len, O; Pigrau, C; Viñado, B | 1 |
| Bushuven, S; Langenhan, R; Probst, A; Reimers, N | 1 |
| El-Shafei, RA; Eladl, AH; Elkenany, RM | 1 |
| Barceló-Vidal, J; Cartagena-Guardado, Y; Castilla-Martí, M; Fernández-Sala, X; Grau, S; Martínez-Palmer, A; Tuñí-Picado, J | 1 |
| Dilhari, A; Fernando, N; Gunasekara, C; McBain, A; Pathirage, S; Weerasekara, D; Weerasekera, M | 1 |
| Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
| Alsousou, J; Dalal, N; Kapoor, B; Kiran, M; Kumar, G; Ralte, P | 1 |
| Abdulla, A; Bos, K; de Winter, BCM; Koch, BCP; Muller, AE; Oosterhoff, M; van Oldenrijk, J; Zhao, Q | 1 |
| Crawford, SB; Davis, WH; Geno, KA; Magee, MR; Monks, SM | 1 |
| Aggor, A; Ankrah, D; Ashubwe-Jalemba, J; Corquaye, O; Hedidor, GK; Owusu, H; Steele-Dadzie, A; Thekkur, P | 1 |
| Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM | 1 |
| Chung, CR; Horng, JT; Lee, TY; Lu, JJ; Wang, HY; Wu, LC; Yao, CH | 1 |
| Cheng, WH; Ho, CH; Su, PY | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Iredell, JR; Partridge, SR; Zong, Z | 1 |
| Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Relaño, MT; Sevillano, D; Torrico, M | 1 |
| Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
| Appelbaum, PC; Ednie, LM; Hawser, S; Lociuro, S; Smith, K | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Klein, CD; van Oosten, LN | 1 |
| Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA | 1 |
5 review(s) available for ciprofloxacin and cefuroxime
| Article | Year |
|---|---|
Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Humans; Ofloxacin; Prodrugs; Skin Diseases, Infectious | 1992 |
Bilateral emphysematous pyelonephritis responding to nonsurgical management.
Topics: Cefuroxime; Ciprofloxacin; Diabetic Nephropathies; Drug Therapy, Combination; Emphysema; Escherichia coli Infections; Female; Humans; Middle Aged; Pyelonephritis | 1995 |
[Purulent pericarditis due to Salmonella enterica subsp. arizonae].
Topics: Amikacin; Animals; Animals, Domestic; Atrial Fibrillation; Cefuroxime; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Humans; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Pericardiocentesis; Pericarditis; Salmonella arizonae; Salmonella Infections; Suppuration; Veterinary Medicine | 2002 |
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Ciprofloxacin; Humans; Linezolid; Microbial Sensitivity Tests; Vancomycin | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 trial(s) available for ciprofloxacin and cefuroxime
| Article | Year |
|---|---|
Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Tobramycin; Treatment Outcome; Urinary Tract Infections | 1992 |
The value of oral antibiotic prophylaxis in biliary tract surgery.
Topics: Anti-Bacterial Agents; Bile; Biliary Tract Surgical Procedures; Cefuroxime; Ciprofloxacin; Drug Costs; Female; Humans; Male; Middle Aged; Surgical Wound Infection | 1991 |
Antibiotic prophylaxis in vaginal hysterectomy. Three doses of cefuroxime plus metronidazole versus one dose of ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Cefuroxime; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Hysterectomy, Vaginal; Injections, Intravenous; Metronidazole; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Urinary Tract Infections | 1990 |
Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Binomial Distribution; Cefuroxime; Cephalosporins; Ciprofloxacin; Double-Blind Method; Humans; Infusions, Intravenous; Logistic Models; Prospective Studies; Surgical Wound Infection; Sweden; Vascular Surgical Procedures | 1995 |
Oral ciprofloxacin as prophylaxis in gastroduodenal surgery.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefuroxime; Ciprofloxacin; Duodenum; Female; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Scotland; Stomach; Surgical Wound Infection | 1995 |
Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 1995 |
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lithotripsy; Male; Middle Aged; Prospective Studies; Time Factors; Ureteral Calculi; Urinary Tract Infections | 1997 |
Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Cervix Uteri; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillinase; Treatment Outcome; Urethra | 1996 |
Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cefuroxime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Random Allocation; Sinusitis | 1998 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Consumer Product Safety; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1998 |
Antibiotic prophylaxis in elective cholecystectomy: a randomized, double blinded study comparing ciprofloxacin and cefuroxime.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Cefuroxime; Cholecystectomy; Ciprofloxacin; Developing Countries; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Surgical Wound Infection | 1999 |
[Antibiotic resistance of E coli isolated from healthy persons].
Topics: Adult; Amdinocillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple; Escherichia coli; Feces; Female; Humans; Male; Middle Aged; Nitrofurantoin; Penicillin Resistance; Prospective Studies; Trimethoprim Resistance | 2001 |
Short-term antibiotic prophylaxis in implant surgery: a comparison of three antibiotics.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prosthesis-Related Infections; Treatment Outcome | 2007 |
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime.
Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Candidiasis, Invasive; Cefuroxime; Ciprofloxacin; Critical Illness; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Single-Blind Method; Thienamycins | 2015 |
111 other study(ies) available for ciprofloxacin and cefuroxime
| Article | Year |
|---|---|
In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Topics: Anti-Infective Agents; Bacteroides fragilis; Ceftazidime; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Imipenem; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Neisseria; Protein Binding; Quinolones | 1992 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
A comparison of antimicrobial activity of ofloxacin, L-ofloxacin, and other oral agents for respiratory pathogens.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Therapy, Combination; Enoxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Conformation; Ofloxacin; Respiratory System; Respiratory Tract Infections; Sputum | 1992 |
In-vitro activity of imipenem, in comparison with cefuroxime and ciprofloxacin, against coagulase-negative staphylococci in broth and peritoneal dialysis fluid.
Topics: Cefuroxime; Ciprofloxacin; Dialysis Solutions; Drug Resistance, Microbial; Humans; Imipenem; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcus | 1992 |
Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.
Topics: Ampicillin; Cefuroxime; Ciprofloxacin; Culture Media; Doxycycline; Drug Resistance, Microbial; Erythromycin; Hemoglobins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Regression Analysis; Reproducibility of Results; Spectinomycin; Tetracycline | 1991 |
Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Carbon Dioxide; Cefuroxime; Ciprofloxacin; Humans; Membrane Proteins; Polystyrenes; Reproducibility of Results; Silicone Elastomers; Staphylococcus; Vancomycin | 1991 |
Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori.
Topics: Animals; Biological Transport; Cefuroxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Gastric Mucosa; Guinea Pigs; Helicobacter pylori; Microbial Sensitivity Tests | 1991 |
Haemolytic uraemic syndrome with shigella.
Topics: Cefuroxime; Ciprofloxacin; Diagnosis, Differential; Dysentery, Bacillary; Fluid Therapy; Hemolytic-Uremic Syndrome; Humans; Hydrocortisone; Male; Middle Aged; Shigella dysenteriae | 1990 |
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
Topics: Bacterial Adhesion; Catheters, Indwelling; Cefuroxime; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Silicone Elastomers; Staphylococcus epidermidis; Vancomycin | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Blood Proteins; Cefuroxime; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Ofloxacin; Oxazines; Protein Binding; Pseudomonas aeruginosa; Quinolines; Quinolones; Staphylococcus; Streptococcus; Trimethoprim | 1988 |
In vitro activity of PD 127,391, an enhanced-spectrum quinolone.
Topics: Anti-Infective Agents; Bacteria; Cefuroxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacteriaceae; Fluoroquinolones; Gentamicins; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nalidixic Acid; Ofloxacin | 1988 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae.
Topics: Agglutination Tests; Bacterial Outer Membrane Proteins; Cefuroxime; Cephalosporins; Ciprofloxacin; Complement C3; Complement System Proteins; Culture Media; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Immunoglobulins; Klebsiella pneumoniae; Lipopolysaccharides | 1987 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
[Successfully treated Salmonella enteritidis endocarditis].
Topics: Brain Diseases; Cefuroxime; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; Hematoma; Humans; Male; Middle Aged; Rheumatic Heart Disease; Salmonella enteritidis; Salmonella Infections; Stereotaxic Techniques; Tomography, X-Ray Computed | 1995 |
In vitro susceptibility of recently isolated respiratory tract pathogens to minocycline and comparable antibiotics. A multicentre study.
Topics: Adult; Amoxicillin; Bacteria; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acids; Doxycycline; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Minocycline; Moraxella catarrhalis; Respiratory System; Streptococcus pneumoniae | 1994 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
The Dambusters: a case of cerebrospinal and urinary obstruction.
Topics: Aged; Catheterization; Cefuroxime; Ciprofloxacin; Escherichia coli Infections; Humans; Hydrocephalus; Male; Meningitis, Bacterial; Osteomyelitis; Urethral Stricture | 1993 |
Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
Topics: Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1996 |
In vitro activity of the tricyclic beta-lactam GV104326.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Cefuroxime; Ciprofloxacin; Haemophilus influenzae; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae | 1996 |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
Hospital-acquired Clostridium difficile diarrhoea.
Topics: Anti-Infective Agents; Cefuroxime; Cephalosporins; Ciprofloxacin; Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillins; Thoracic Diseases | 1997 |
Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefuroxime; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Flow Cytometry; Fluorescent Dyes; Isoxazoles; Microbial Sensitivity Tests | 1997 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Bone Conduction; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Glucocorticoids; Hearing Loss; Hearing Loss, Conductive; Humans; Male; Middle Aged; Otitis Media; Penicillins; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
Antimicrobial susceptibility of oral isolates of Enterobacter cloacae and Klebsiella pneumoniae from a southern Chinese population.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ceftazidime; Cefuroxime; Cephalothin; Child; Ciprofloxacin; Diet, Vegetarian; Drug Resistance, Microbial; Enterobacter cloacae; Gentamicins; Hong Kong; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mouth; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; Time Factors | 1999 |
Primary meningococcal arthritis in the elderly.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Arthritis, Infectious; Cefuroxime; Cephalosporins; Ciprofloxacin; Humans; Injections, Intravenous; Knee Joint; Male; Meningococcal Infections; Neisseria meningitidis; Synovial Fluid; Treatment Outcome | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Anterior chest wall abscess caused by Salmonella enteritidis in a healthy adult.
Topics: Abscess; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Ciprofloxacin; Humans; Male; Middle Aged; Salmonella enteritidis; Salmonella Infections; Thoracic Diseases | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Increasing antibiotic resistance among urinary tract isolates.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Kidney Diseases; Retrospective Studies; Trimethoprim Resistance; Urinary Tract; Urinary Tract Infections | 2003 |
[Antibiotic resistance and the detection in respiratory tract isolate of Moraxella catarrhalis].
Topics: Aged; Cefotaxime; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Cough; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Pharynx | 2003 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cats; Cefuroxime; Ciprofloxacin; Female; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Pasteurella Infections; Quinolines; Streptococcal Infections; Treatment Failure; Wound Infection | 2005 |
University-acquired pneumonia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Community-Acquired Infections; Erythromycin; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Pneumonia, Bacterial; Students | 2006 |
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom.
Topics: Anti-Bacterial Agents; Benchmarking; Cefuroxime; Ciprofloxacin; Cohort Studies; Data Collection; Drug Prescriptions; Drug Utilization; Hospitals; Humans; Isoniazid; Medication Systems, Hospital; Pharmacy Service, Hospital; Pilot Projects; Practice Guidelines as Topic; Practice Patterns, Physicians'; Rifampin; United Kingdom | 2008 |
Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacterial Infections; Cefuroxime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies | 2007 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis as Topic; Metronidazole; Ofloxacin; Pancreatitis; Randomized Controlled Trials as Topic | 2009 |
In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
Topics: Anti-Bacterial Agents; Bacteria; Cefuroxime; Ciprofloxacin; Drug Resistance, Microbial; England; Eye Infections, Bacterial; Gentamicins; Humans; Keratitis; Microbial Sensitivity Tests; Retrospective Studies | 2011 |
Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Cefuroxime; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; United Kingdom | 2011 |
Bacteriological agents of chronic discharging ears and their antibiotic sensitivity pattern in Ido - Ekiti, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infant; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Nigeria; Otitis Media, Suppurative; Prospective Studies; Proteus; Pseudomonas; Staphylococcus aureus; Young Adult | 2012 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Incidence; Male; Microbial Sensitivity Tests; Nitrofurantoin; Prevalence; Retrospective Studies; Time Factors; Trimethoprim; Urinary Tract Infections | 2013 |
Cost effectiveness of three drugs for the treatment of S. aureus infections in Nigeria.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Cost-Benefit Analysis; Gentamicins; Humans; Nigeria; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2012 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
[Isolation of Salmonella enterica serovar Typhi in a mesenteric adenopathy].
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Humans; Lymph Nodes; Male; Mesentery; Salmonella typhi; Typhoid Fever | 2013 |
Helicobacter canis bacteremia in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Female; Graft Rejection; Helicobacter; Helicobacter Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Prednisolone; Sequence Analysis, DNA; Tacrolimus | 2014 |
[Infection of the hand: evaluation of a two-stage therapy].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bandages; Cefuroxime; Ciprofloxacin; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Hand Injuries; Humans; Infusions, Intravenous; Male; Middle Aged; Reoperation; Retrospective Studies; Wound Closure Techniques; Wound Healing; Wound Infection; Young Adult | 2014 |
Synergistic activity of biocides and antibiotics on resistant bacteria from organically produced foods.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Chryseobacterium; Ciprofloxacin; Disinfectants; Drug Resistance, Bacterial; Drug Synergism; Enterobacter; Enterococcus; Erythromycin; Food, Organic; Klebsiella; Lactobacillus; Microbial Sensitivity Tests; Micrococcus; Pantoea; Salmonella; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
Environmental risk assessment of selected pharmaceuticals in Turkey.
Topics: 1-Octanol; Acetaminophen; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzalkonium Compounds; Cefuroxime; Ciprofloxacin; Clarithromycin; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Risk Assessment; Sewage; Turkey; Water; Water Pollutants, Chemical | 2014 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |
Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Cefuroxime; Ciprofloxacin; Cohort Studies; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Forecasting; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Multivariate Analysis; Phylogeny; Prospective Studies; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2015 |
Endodontic drug delivery for root surface disinfection: a laboratory feasibility evaluation.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cattle; Cefuroxime; Ciprofloxacin; Disinfection; Drug Combinations; Fusobacterium nucleatum; In Vitro Techniques; Metronidazole; Root Canal Irrigants; Tooth Root | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Topics: Acute Disease; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Empirical Research; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Risk Factors; Spain; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2017 |
Peri-operative antibiotic treatment of bacteriuria reduces early deep surgical site infections in geriatric patients with proximal femur fracture.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Cefuroxime; Ciprofloxacin; Female; Femoral Fractures; Humans; Male; Orthopedic Procedures; Prospective Studies; Retrospective Studies; Surgical Wound Infection; Urine | 2018 |
Genetic characterisation of class 1 integrons among multidrug-resistant Salmonella serotypes in broiler chicken farms.
Topics: Animals; Azithromycin; Cefuroxime; Chickens; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Egypt; Integrons; Phylogeny; Salmonella; Salmonella enterica; Sequence Analysis, DNA; Serogroup; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Infectious postoperative endophthalmitis after cataract surgery performed over 7 years. The role of azithromycin versus ciprofloxacin eye drops.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cataract Extraction; Cefuroxime; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Male; Ophthalmic Solutions; Postoperative Complications | 2018 |
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefuroxime; Ciprofloxacin; Cloxacillin; Debridement; Diabetes Mellitus, Type 2; Female; Gram-Negative Bacterial Infections; Humans; Leg Ulcer; Microbial Sensitivity Tests; Paratyphoid Fever; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella paratyphi A; Wound Healing | 2020 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Is a single dose of preoperative antibiotic therapy effective for patients treated with megaendoprosthesis after metastatic bone tumour resection?
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bone Neoplasms; Cefuroxime; Ciprofloxacin; Humans; Penicillins; Prospective Studies; Teicoplanin | 2022 |
Assessment of nationally recommended antibiotics for treatment of UTI in U.S.-Mexico border emergency departments.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cefuroxime; Cephalexin; Ciprofloxacin; Emergency Service, Hospital; Fluoroquinolones; Humans; Levofloxacin; Mexico; Nitrofurantoin; Retrospective Studies; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2022 |
Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019-2021.
Topics: Adult; Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Cross-Sectional Studies; Female; Ghana; Health Facilities; Humans; Male; Urinary Tract Infections | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifloxacin; Humans; Longitudinal Studies; Moxifloxacin; Ofloxacin; Retrospective Studies | 2022 |
Data-Driven Two-Stage Framework for Identification and Characterization of Different Antibiotic-Resistant Escherichia coli Isolates Based on Mass Spectrometry Data.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cefuroxime; Ciprofloxacin; Escherichia coli; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefuroxime; Ciprofloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Urine bactericidal activity against Escherichia coli isolates exhibiting different resistance phenotypes/genotypes in an in vitro pharmacodynamic model simulating urine concentrations obtained after oral administration of a 400-milligram single dose of ce
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Microbial Sensitivity Tests; Models, Biological; Phenotype; Urinary Tract Infections; Urine | 2008 |
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Antistreptococcal activity of AR-709 compared to that of other agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Streptococcus pneumoniae; Streptococcus pyogenes; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Comparative antipneumococcal activities of sulopenem and other drugs.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship | 2022 |